MSC-Derived Extracellular Vesicle-Delivered L-PGDS Inhibit Gastric Cancer Progression by Suppressing Cancer Cell Stemness and STAT3 Phosphorylation
Mesenchymal stem cell- (MSC-) derived extracellular vesicles (EVs) serving as delivery system have attracted extensive research interest, especially in cancer therapy. In our previous study, lipocalin-type prostaglandin D2 synthase (L-PGDS) showed inhibitory effects on gastric cancer growth. In this...
Saved in:
Main Authors: | Benshuai You, Can Jin, Jiaxin Zhang, Min Xu, Wenrong Xu, Zixuan Sun, Hui Qian |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-01-01
|
Series: | Stem Cells International |
Online Access: | http://dx.doi.org/10.1155/2022/9668239 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Optimizing therapeutic outcomes: preconditioning strategies for MSC-derived extracellular vesicles
by: Yuqi Song, et al.
Published: (2025-02-01) -
Diagnostic Value of Glycosylated Extracellular Vesicle microRNAs in Gastric Cancer
by: Wang S, et al.
Published: (2025-01-01) -
Pathogenic and therapeutic roles of extracellular vesicles in sepsis
by: Benshuai You, et al.
Published: (2025-02-01) -
Biology of extracellular vesicles and the potential of tumor-derived vesicles for subverting immunotherapy of cancer
by: Theresa L Whiteside
Published: (2025-01-01) -
Sigma1 inhibitor suppression of adaptive immune resistance mechanisms mediated by cancer cell derived extracellular vesicles
by: Paola A. Castagnino, et al.
Published: (2025-12-01)